Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass
- 31 May 1993
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 55 (5) , 1205-1209
- https://doi.org/10.1016/0003-4975(93)90035-g
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypassThe Annals of Thoracic Surgery, 1991
- Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypassThe Lancet, 1991
- Low dose Aprotinin as blood saver in open heart surgeryEuropean Journal of Cardio-Thoracic Surgery, 1991
- Plasma a2-Antiplasmin ActivityArchives of internal medicine (1960), 1989
- Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical PatientsThe Thoracic and Cardiovascular Surgeon, 1989
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Blood Conservation with Membrane Oxygenators and DipyridamoleThe Annals of Thoracic Surgery, 1987
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- Enhanced fibrinolytic activity during cardiopulmonary bypass in open‐heart surgery in man is caused by extrinsic (tissue‐type) plasminogen activatorEuropean Journal of Clinical Investigation, 1984